| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/28/2007 | CN1922196A Crystalline forms of a pharmaceutical compound |
| 02/28/2007 | CN1922186A Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands |
| 02/28/2007 | CN1922176A Condensed bicycle heterocycle substituted quinuclidine derivant |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1922157A Benzo[d]isoxazol-3-ol daao inhibitors |
| 02/28/2007 | CN1922156A Substituted triazoles as sodium channel blockers |
| 02/28/2007 | CN1922150A Indazole derivatives and pharmaceutical compositions containing them |
| 02/28/2007 | CN1922144A Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1921856A Dpp-iv inhibitors for treating neurodegeneration and cognitive disorders |
| 02/28/2007 | CN1921854A Heterocyclic GABAA subtype selective receptor modulators |
| 02/28/2007 | CN1921848A Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 02/28/2007 | CN1921847A 氨基醇化合物 Amino alcohol compound |
| 02/28/2007 | CN1921846A Combinatorial therapy with an acetylcholinesterase inhibitor and (3AR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
| 02/28/2007 | CN1921844A Use of cholinesterase inhibitors for treating vascular depression |
| 02/28/2007 | CN1921841A Amines and amides for the treatment of diseases |
| 02/28/2007 | CN1921838A Extended release pharmaceutical compositions of divalproex sodium |
| 02/28/2007 | CN1919868A Chronic neuralgia related albumen and gene thereof |
| 02/28/2007 | CN1919853A Phosphor isoquinolinone, derivative, synthesis method and use thereof |
| 02/28/2007 | CN1919847A Novel hydrochloride compound and use thereof |
| 02/28/2007 | CN1919313A Decoction medicine for treating headache of the liver yang hyperactivity type and its preparing process |
| 02/28/2007 | CN1919306A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919305A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919304A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919303A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919301A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919273A Chinese medicinal composition for treating headache |
| 02/28/2007 | CN1919272A Traditional Chinese medicine concentrated pill |
| 02/28/2007 | CN1919265A Decoction medicine for treating headache due to insufficiency of both qi and blood and its preparing process |
| 02/28/2007 | CN1919262A Decoction medicine for treating obstinate headache and its preparing process |
| 02/28/2007 | CN1919261A Decoction medicine for treating headache due to stagnancy of qi and blood stasis and its preparing process |
| 02/28/2007 | CN1919260A Tranquilization, stomach nourition, and beauty treatment capsule and its preparation method |
| 02/28/2007 | CN1919255A Aim Naoluotong drop pill and its preparation method |
| 02/28/2007 | CN1919233A Nourishing and health care capsule with intelligence development and memory improvement function and method for making same |
| 02/28/2007 | CN1919231A Numbness solution |
| 02/28/2007 | CN1919217A Capsule made of ant extract, spirulina platensis dry powder and chinese caterpillar fungus extract |
| 02/28/2007 | CN1919201A Compounds and methods for therapeutic intervention in preventing diabetic complications |
| 02/28/2007 | CN1919199A Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 02/28/2007 | CN1301991C Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 02/28/2007 | CN1301988C Method of extracting terpene lactone from folium ginkgo leaves and product |
| 02/28/2007 | CN1301975C 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/28/2007 | CN1301972C Piperidine compounds as muscarinic antagonists |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2007 | CN1301746C Chinese traditional medicine for treating epilepsy and epilepsy |
| 02/28/2007 | CN1301710C Therapeutic methods and compositions involving isoflavones |
| 02/28/2007 | CA2557246A1 Nk3 receptor in vivo assay |
| 02/27/2007 | US7183440 Pharmaceutically useful compounds |
| 02/27/2007 | US7183436 Substituted 4-aminocyclohexanols |
| 02/27/2007 | US7183430 Compounds which can block the response to chemical substances or thermal stimuli or mediators of inflammation of nociceptors, production method thereof and compositions containing same |
| 02/27/2007 | US7183415 Melanin-concentrating hormone antagonistic action for treating obesity, for example 4'-fluoro-N-[8-methyl-3-(1-pyrrolidinylmethyl)-7-quinolinyl][1,1'-biphenyl]-4-carboxamide |
| 02/27/2007 | US7183400 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes |
| 02/27/2007 | US7183375 Invention relates to peptide sequence which inhibits cleavage of calcineurin subunit A by calpain; cell death suppressant targeting the mechanism of the long term activation of calcineurin but not the calcineurin activation through the transient increase of the intracellular concentration of calcium |
| 02/27/2007 | US7183323 Sodium channel modulators |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183311 NF-κB inhibitors |
| 02/27/2007 | US7183307 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/27/2007 | US7183304 Heterocyclic compounds and methods of use |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 02/27/2007 | US7183290 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
| 02/27/2007 | US7183283 5-{2-[4-[1-(4-fluoro-2-hydroxy-phenyl)-methanoyl]-piperidine-1-yl]-(ethyl or propyl)amino}-(optional 2-alkyl)-2H-pyridazine-3-one; hydrogenation of the isoxazolyl-alkylamino-pyridazinone; anxiolytic agents |
| 02/27/2007 | US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 02/27/2007 | US7183277 Alpha-((aryl or heteroaryl)ureido or carbamoyloxy)-N-heteroaryl amides; blood-coagulation factor Xa and VIIa inhibitors; synergistic mixtures with other antitumor agents or anticoagulants |
| 02/27/2007 | US7183276 5-carbonyl or carbamido-4-(4-chlorophenyl)-2-heteroaryl oxazoles; analgesic for diabetic neuropathy |
| 02/27/2007 | US7183272 Crystal forms of oxcarbazepine and processes for their preparation |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/27/2007 | US7183078 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 02/27/2007 | US7183075 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 02/27/2007 | US7183070 Using reduction in beta site amyloid precursor protein cleaving enzyme activity, manifested as decreased beta amyloid peptides production, as diagnostic indicator of enzyme inhibition; for use in treatment of amyloid deposition disorders |
| 02/27/2007 | CA2256410C Stable pharmaceutical composition of bdnf |
| 02/23/2007 | WO2007021308A1 Metabotropic glutamate-receptor-potentiating isoindolones |
| 02/22/2007 | WO2007022535A2 Prodrugs of active agents |
| 02/22/2007 | WO2007022305A2 2-aminoimidazopyridines for treating neurodegenerative diseases |
| 02/22/2007 | WO2007022280A1 Phosphodiesterase 10 inhibitors |
| 02/22/2007 | WO2007022182A1 Neurorestoration with r(+) pramipexole |
| 02/22/2007 | WO2007022068A1 Olanzapine analogs and methods of use thereof |
| 02/22/2007 | WO2007021982A2 Modulators of cystic fibrosis transmembrane conductance regulator |
| 02/22/2007 | WO2007021793A1 Macrocyclic diaminopropanes as beta-secretase inhibitors |
| 02/22/2007 | WO2007021574A1 Bicyclic piperazines as metabotropic glutamate receptor antagonists |
| 02/22/2007 | WO2007021573A1 Substituted piperazines as metabotropic glutamate receptor antagonists |
| 02/22/2007 | WO2007021309A1 Substituted isoindolones and their use as metabotropic glutamate receptor potentiators |
| 02/22/2007 | WO2007021189A2 Method of treating parturient placental mammals in order to reduce maternal and/or utirine exhaustion |
| 02/22/2007 | WO2007021061A1 Composition comprising oleic acid and the use thereof |
| 02/22/2007 | WO2007020935A1 Therapeutic agent for pain comprising p2y12 receptor and/or p2y14 receptor blocker |
| 02/22/2007 | WO2007020922A1 Remedy and preventive for cerebral diseases |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007020672A2 Use of nerve growth factor in eye-drops for therapy of pathologies of the central nervous system, such as alzheimer's and parkinson's disease |
| 02/22/2007 | WO2007020653A1 Thioether derivatives as functional 5-ht6 ligands |
| 02/22/2007 | WO2007020459A2 Antisense oligonucleotides against protein kinase isoforms alpha, beta and gamma |
| 02/22/2007 | WO2007020403A1 Azapeptides for treating hyperalgesic pain conditions |
| 02/22/2007 | WO2007020386A2 Apoe mimetic agents |
| 02/22/2007 | WO2007020344A1 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 02/22/2007 | WO2007020343A1 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 02/22/2007 | WO2007020337A1 Combination of a long-acting hypnotic agent and a short-acting hypnotic agent and therapeutic use of same |
| 02/22/2007 | WO2007020286A2 Method of using potassium channel inhibiting compounds |
| 02/22/2007 | WO2007020261A2 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 02/22/2007 | WO2007020190A1 Fluoro substituted 2-oxo azepan derivatives |
| 02/22/2007 | WO2007019987A1 Substituted 8-(3-aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4,5]decan-4-on-derivatives for use in pain therapy |
| 02/22/2007 | WO2007019880A1 Use of a selective inhibitor of norepinephrine reuptake for treating respiratory disorders resulting from rett syndrome |